Publisher
Springer Berlin Heidelberg
Reference80 articles.
1. Agus DB, Scher HI, Higgins B, Fox WD, Heller G, Fazzari M, Cordon-Cardo C, Golde DW (1999) Response of prostate cancer to anti-Her-2/neu antibody in androgen-dependent and-independent human xenograft models. Cancer Res 59:4761–4764
2. Alers JC, Krijtenburg PJ, Vis AN, Hoedemaeker RF, Wildhagen MF, Hop WC, van Der Kwast TH, Schroder FH, Tanke HJ, van Dekken H (2001) Molecular cytogenetic analysis of prostatic adenocarcinomas from screening studies: early cancers may contain aggressive genetic features. Am J Pathol 158:399–406
3. Aurich-Costa J, Vannier A, Gregoire E, Nowak F, Cherif D (2001) IPM-FISH, a new M-FISH approach using IRS-PCR painting probes: application to the analysis of seven human prostate cell lines. Genes Chromosomes Cancer 30:143–160
4. Balleine RL, Fejzo MS, Sathasivam P, Basset P, Clarke CL, Byrne JA (2000) The hD52 (TPD52) gene is a candidate target gene for events resulting in increased 8q2i copy number in human breast carcinoma. Genes Chromosomes Cancer 29:48–57
5. Bernardino J, Bourgeois CA, Muleris M, Dutrillaux AM, Malfoy B, Dutrillaux B (1997) Characterization of chromosome changes in two human prostatic carcinoma cell lines (PC-3 and DU145) using chromosome painting and comparative genomic hybridization. Cancer Genet Cytogenet 96:123–128